文献速递湿疹皮炎与荨麻疹

美国特应性皮炎急诊就诊的经济负担

Financial burden of emergency department visits for atopic dermatitis in the United States.
PubMed 文献 · J Am Acad Dermatol · 2018-05-23

基于2006-2012年美国全国急诊样本的横断面研究显示,特应性皮炎或湿疹(AD-E)作为主要诊断的急诊就诊年均发病率为3368.4-3553.0例/百万人,2006-2012年间患病率显著上升(调查逻辑回归,P<.05)。AD-E相关急诊就诊的几何均值和总费用分别从2006年的369.07美元和127,275,080美元增至2012年的642.10美元和265,541,084美元。

要点

  • AD-E急诊就诊年均发病率为3368.4-3553.0例/百万人,2006-2012年患病率显著上升。
  • AD-E急诊就诊更多见于年轻患者、医疗补助或无保险者、较低家庭收入四分位人群,以及周末和夏季。
  • AD-E急诊就诊几何均值费用从2006年369.07美元升至2012年642.10美元,总费用从127,275,080美元升至265,541,084美元。

核心结论

  • 美国AD-E急诊就诊存在巨大且不断增长的经济负担。
  • 需要干预措施以减少AD的急诊就诊。

研究设计与样本

  • 横断面研究,使用2006-2012年美国全国急诊样本,包含全美20%的急诊就诊(n=198,102,435)。

主要发现

  • 以AD-E为主要诊断的急诊就诊年均发病率为3368.4-3553.0例/百万人。
  • 2006-2012年间AD-E急诊就诊患病率显著增加(调查逻辑回归,P<.05)。
  • 与无AD-E主要诊断的急诊就诊相比,AD-E急诊就诊与更年轻的患者年龄、医疗补助或无保险、较低家庭收入四分位相关,且更可能发生在周末和夏季月份。
  • AD-E急诊就诊的几何均值费用从2006年369.07美元增至2012年642.10美元,总费用从2006年127,275,080美元增至2012年265,541,084美元,均显著增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 全国急诊样本未包含AD严重程度、反复急诊就诊、种族/民族或所提供治疗的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the usage and financial burden of emergency care visits for atopic dermatitis (AD) or eczema (AD-E) in the United States. OBJECTIVE: To determine the prevalence, risk factors, and cost of emergency care for AD-E in the United States. METHODS: Cross-sectional study of the 2006-2012 National Emergency Department Sample, including a 20% sample of emergency department (ED) visits throughout the United States (n = 198,102,435). RESULTS: The mean annual incidence of ED visits with a primary diagnosis of AD-E was 3368.4-3553.0 cases/1 million persons. The prevalence of ED visits for AD-E increased significantly during 2006-2012 (survey logistic regression, P < .05). ED visits with a primary diagnosis of AD-E versus ED visits without were associated with younger patient age, Medicaid or no insurance, and lower household income quartile and more likely to occur during weekends and summer months. The geometric mean and total costs of ED visits for AD-E significantly increased from $369.07 and $127,275,080, respectively, in 2006 to $642.10 and $265,541,084, respectively, in 2012. LIMITATIONS: The National Emergency Department Sample did not include data on AD severity, recurrent ED visits, race/ethnicity, or treatments provided. CONCLUSION: There is a substantial and increasing financial burden of ED visits for AD-E in the United States. Interventions are needed to decrease ED visits for AD.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Kwa L, Silverberg JI. Financial burden of emergency department visits for atopic dermatitis in the United States. J Am Acad Dermatol. 2018. PMID: 29800581. doi:10.1016/j.jaad.2018.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。